KEGG   Miniopterus natalensis: 107525695
Entry
107525695         CDS       T05883                                 

Gene name
MAP2K2
Definition
(RefSeq) dual specificity mitogen-activated protein kinase kinase 2
  KO
K04369  mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
Organism
mna  Miniopterus natalensis
Pathway
mna01521  EGFR tyrosine kinase inhibitor resistance
mna01522  Endocrine resistance
mna04010  MAPK signaling pathway
mna04012  ErbB signaling pathway
mna04014  Ras signaling pathway
mna04015  Rap1 signaling pathway
mna04022  cGMP-PKG signaling pathway
mna04024  cAMP signaling pathway
mna04066  HIF-1 signaling pathway
mna04068  FoxO signaling pathway
mna04071  Sphingolipid signaling pathway
mna04072  Phospholipase D signaling pathway
mna04140  Autophagy - animal
mna04150  mTOR signaling pathway
mna04151  PI3K-Akt signaling pathway
mna04210  Apoptosis
mna04218  Cellular senescence
mna04270  Vascular smooth muscle contraction
mna04370  VEGF signaling pathway
mna04371  Apelin signaling pathway
mna04540  Gap junction
mna04550  Signaling pathways regulating pluripotency of stem cells
mna04613  Neutrophil extracellular trap formation
mna04620  Toll-like receptor signaling pathway
mna04650  Natural killer cell mediated cytotoxicity
mna04660  T cell receptor signaling pathway
mna04662  B cell receptor signaling pathway
mna04664  Fc epsilon RI signaling pathway
mna04720  Long-term potentiation
mna04722  Neurotrophin signaling pathway
mna04730  Long-term depression
mna04810  Regulation of actin cytoskeleton
mna04910  Insulin signaling pathway
mna04912  GnRH signaling pathway
mna04915  Estrogen signaling pathway
mna04916  Melanogenesis
mna04917  Prolactin signaling pathway
mna04919  Thyroid hormone signaling pathway
mna04921  Oxytocin signaling pathway
mna04926  Relaxin signaling pathway
mna04929  GnRH secretion
mna04934  Cushing syndrome
mna04935  Growth hormone synthesis, secretion and action
mna05010  Alzheimer disease
mna05022  Pathways of neurodegeneration - multiple diseases
mna05132  Salmonella infection
mna05135  Yersinia infection
mna05160  Hepatitis C
mna05161  Hepatitis B
mna05163  Human cytomegalovirus infection
mna05164  Influenza A
mna05165  Human papillomavirus infection
mna05166  Human T-cell leukemia virus 1 infection
mna05167  Kaposi sarcoma-associated herpesvirus infection
mna05170  Human immunodeficiency virus 1 infection
mna05200  Pathways in cancer
mna05205  Proteoglycans in cancer
mna05206  MicroRNAs in cancer
mna05210  Colorectal cancer
mna05211  Renal cell carcinoma
mna05213  Endometrial cancer
mna05214  Glioma
mna05215  Prostate cancer
mna05216  Thyroid cancer
mna05218  Melanoma
mna05219  Bladder cancer
mna05220  Chronic myeloid leukemia
mna05221  Acute myeloid leukemia
mna05223  Non-small cell lung cancer
mna05224  Breast cancer
mna05225  Hepatocellular carcinoma
mna05226  Gastric cancer
mna05230  Central carbon metabolism in cancer
mna05231  Choline metabolism in cancer
mna05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
KEGG Orthology (KO) [BR:mna00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    107525695 (MAP2K2)
   04012 ErbB signaling pathway
    107525695 (MAP2K2)
   04014 Ras signaling pathway
    107525695 (MAP2K2)
   04015 Rap1 signaling pathway
    107525695 (MAP2K2)
   04370 VEGF signaling pathway
    107525695 (MAP2K2)
   04371 Apelin signaling pathway
    107525695 (MAP2K2)
   04066 HIF-1 signaling pathway
    107525695 (MAP2K2)
   04068 FoxO signaling pathway
    107525695 (MAP2K2)
   04072 Phospholipase D signaling pathway
    107525695 (MAP2K2)
   04071 Sphingolipid signaling pathway
    107525695 (MAP2K2)
   04024 cAMP signaling pathway
    107525695 (MAP2K2)
   04022 cGMP-PKG signaling pathway
    107525695 (MAP2K2)
   04151 PI3K-Akt signaling pathway
    107525695 (MAP2K2)
   04150 mTOR signaling pathway
    107525695 (MAP2K2)
 09140 Cellular Processes
  09141 Transport and catabolism
   04140 Autophagy - animal
    107525695 (MAP2K2)
  09143 Cell growth and death
   04210 Apoptosis
    107525695 (MAP2K2)
   04218 Cellular senescence
    107525695 (MAP2K2)
  09144 Cellular community - eukaryotes
   04540 Gap junction
    107525695 (MAP2K2)
   04550 Signaling pathways regulating pluripotency of stem cells
    107525695 (MAP2K2)
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    107525695 (MAP2K2)
 09150 Organismal Systems
  09151 Immune system
   04613 Neutrophil extracellular trap formation
    107525695 (MAP2K2)
   04620 Toll-like receptor signaling pathway
    107525695 (MAP2K2)
   04650 Natural killer cell mediated cytotoxicity
    107525695 (MAP2K2)
   04660 T cell receptor signaling pathway
    107525695 (MAP2K2)
   04662 B cell receptor signaling pathway
    107525695 (MAP2K2)
   04664 Fc epsilon RI signaling pathway
    107525695 (MAP2K2)
  09152 Endocrine system
   04910 Insulin signaling pathway
    107525695 (MAP2K2)
   04929 GnRH secretion
    107525695 (MAP2K2)
   04912 GnRH signaling pathway
    107525695 (MAP2K2)
   04915 Estrogen signaling pathway
    107525695 (MAP2K2)
   04917 Prolactin signaling pathway
    107525695 (MAP2K2)
   04921 Oxytocin signaling pathway
    107525695 (MAP2K2)
   04926 Relaxin signaling pathway
    107525695 (MAP2K2)
   04935 Growth hormone synthesis, secretion and action
    107525695 (MAP2K2)
   04919 Thyroid hormone signaling pathway
    107525695 (MAP2K2)
   04916 Melanogenesis
    107525695 (MAP2K2)
  09153 Circulatory system
   04270 Vascular smooth muscle contraction
    107525695 (MAP2K2)
  09156 Nervous system
   04720 Long-term potentiation
    107525695 (MAP2K2)
   04730 Long-term depression
    107525695 (MAP2K2)
   04722 Neurotrophin signaling pathway
    107525695 (MAP2K2)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    107525695 (MAP2K2)
   05206 MicroRNAs in cancer
    107525695 (MAP2K2)
   05205 Proteoglycans in cancer
    107525695 (MAP2K2)
   05230 Central carbon metabolism in cancer
    107525695 (MAP2K2)
   05231 Choline metabolism in cancer
    107525695 (MAP2K2)
   05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
    107525695 (MAP2K2)
  09162 Cancer: specific types
   05210 Colorectal cancer
    107525695 (MAP2K2)
   05225 Hepatocellular carcinoma
    107525695 (MAP2K2)
   05226 Gastric cancer
    107525695 (MAP2K2)
   05214 Glioma
    107525695 (MAP2K2)
   05216 Thyroid cancer
    107525695 (MAP2K2)
   05221 Acute myeloid leukemia
    107525695 (MAP2K2)
   05220 Chronic myeloid leukemia
    107525695 (MAP2K2)
   05218 Melanoma
    107525695 (MAP2K2)
   05211 Renal cell carcinoma
    107525695 (MAP2K2)
   05219 Bladder cancer
    107525695 (MAP2K2)
   05215 Prostate cancer
    107525695 (MAP2K2)
   05213 Endometrial cancer
    107525695 (MAP2K2)
   05224 Breast cancer
    107525695 (MAP2K2)
   05223 Non-small cell lung cancer
    107525695 (MAP2K2)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    107525695 (MAP2K2)
   05022 Pathways of neurodegeneration - multiple diseases
    107525695 (MAP2K2)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    107525695 (MAP2K2)
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    107525695 (MAP2K2)
   05135 Yersinia infection
    107525695 (MAP2K2)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    107525695 (MAP2K2)
   05170 Human immunodeficiency virus 1 infection
    107525695 (MAP2K2)
   05161 Hepatitis B
    107525695 (MAP2K2)
   05160 Hepatitis C
    107525695 (MAP2K2)
   05164 Influenza A
    107525695 (MAP2K2)
   05163 Human cytomegalovirus infection
    107525695 (MAP2K2)
   05167 Kaposi sarcoma-associated herpesvirus infection
    107525695 (MAP2K2)
   05165 Human papillomavirus infection
    107525695 (MAP2K2)
  09176 Drug resistance: antineoplastic
   01521 EGFR tyrosine kinase inhibitor resistance
    107525695 (MAP2K2)
   01522 Endocrine resistance
    107525695 (MAP2K2)
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01001 Protein kinases [BR:mna01001]
    107525695 (MAP2K2)
Enzymes [BR:mna01000]
 2. Transferases
  2.7  Transferring phosphorus-containing groups
   2.7.12  Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
    2.7.12.2  mitogen-activated protein kinase kinase
     107525695 (MAP2K2)
Protein kinases [BR:mna01001]
 Serine/threonine kinases: STE group
  STE7 family
   107525695 (MAP2K2)
SSDB
Motif
Pfam: Pkinase PK_Tyr_Ser-Thr Pkinase_fungal Kinase-like APH Seadorna_VP7 Kdo
Other DBs
NCBI-GeneID: 107525695
NCBI-ProteinID: XP_016053423
LinkDB
Position
Unknown
AA seq 444 aa
MKTGILAWDFTRLMPSFISPVPCLLSEWSGALVSERRTPESGTRAIEPELAFQVLRSPNL
SCTLFTNRCPWGLCRANLVDLQKKLEELELDEQQKKRLEAFLTQKAKVGELKDDDFERIS
ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA
FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK
PSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS
LVELSIGRYPIPPPDAKELEAIFGRPMVDGAEGEPHSISPRPRPPGRPISGHGVDSRPAM
AIFELLDYIVNEPPPKLPSGVFTQDFQEFVSKCLIKNPAERADLKMLMNHGFIKRSEVEE
VDFAGWLCKTLRLNQPSTPTRTAV
NT seq 1335 nt   +upstreamnt  +downstreamnt
atgaagacaggcatcctggcctgggacttcactcgcctgatgcccagttttatctcccca
gttccatgtctcctttcagagtggtcgggagcccttgtgtcagaaaggaggactcctgaa
tctggtaccagggccattgaaccagagctggccttccaggtcctgaggtctcctaaccta
tcttgcacactcttcactaaccgttgcccttggggtctctgcagagcaaacttggtggat
ctccagaagaagctagaggagctagagcttgacgagcagcagaagaagcgtctagaagcc
ttcctcacccagaaggccaaggttggggagctcaaggatgatgacttcgaaaggatctca
gagctgggagccgggaacggcggggtggtcaccaaggtccagcacagaccttcaggcctc
ataatggcaagaaagctgattcacctggagatcaagccggccatccggaaccagatcatc
cgcgagctacaggtgctgcatgagtgtaattccccatacattgtgggcttctacggggcc
ttctacagcgatggggagatcagcatctgcatggagcacatggacggtggctctctggac
caggtgttgaaagaagccaagagaattccagaagaaatcctggggaaggtcagcattgcg
gttctacggggcctggcgtatctccgggaaaagcaccagatcatgcaccgagatgtgaaa
ccatctaacatcctcgtcaactccagaggggagatcaagctgtgcgattttggggtgagc
gggcagctcatcgactccatggccaactccttcgtgggaactcgatcctacatgtctcca
gagcgattgcaaggcactcactactctgtgcagtcggacatctggagcatgggcctgtcc
ctggtggagctgtccatcggaaggtaccccatccccccaccagatgccaaggagctggaa
gctatatttggccggcccatggtcgatggggcagaaggagagcctcacagcatctcacct
cggccaagaccccccggacgccccatcagtggtcacggggtggacagtcgaccagctatg
gctatctttgaactcctggactatattgtgaatgagcctcctcctaagctgcccagtggc
gtcttcacccaggacttccaggagtttgtgagtaaatgcctaattaagaacccagccgaa
cgagcagatctgaagatgctcatgaaccatggcttcatcaaacggtccgaggtggaagaa
gtggattttgctggctggttgtgtaaaacgctgcgtctgaaccagcccagcacgcccacg
cgtaccgctgtgtga

KEGG   Miniopterus natalensis: 107533801
Entry
107533801         CDS       T05883                                 

Gene name
MAP2K1
Definition
(RefSeq) dual specificity mitogen-activated protein kinase kinase 1
  KO
K04368  mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
Organism
mna  Miniopterus natalensis
Pathway
mna01521  EGFR tyrosine kinase inhibitor resistance
mna01522  Endocrine resistance
mna04010  MAPK signaling pathway
mna04012  ErbB signaling pathway
mna04014  Ras signaling pathway
mna04015  Rap1 signaling pathway
mna04022  cGMP-PKG signaling pathway
mna04024  cAMP signaling pathway
mna04062  Chemokine signaling pathway
mna04066  HIF-1 signaling pathway
mna04068  FoxO signaling pathway
mna04071  Sphingolipid signaling pathway
mna04072  Phospholipase D signaling pathway
mna04114  Oocyte meiosis
mna04140  Autophagy - animal
mna04150  mTOR signaling pathway
mna04151  PI3K-Akt signaling pathway
mna04210  Apoptosis
mna04218  Cellular senescence
mna04270  Vascular smooth muscle contraction
mna04370  VEGF signaling pathway
mna04371  Apelin signaling pathway
mna04380  Osteoclast differentiation
mna04510  Focal adhesion
mna04540  Gap junction
mna04550  Signaling pathways regulating pluripotency of stem cells
mna04613  Neutrophil extracellular trap formation
mna04620  Toll-like receptor signaling pathway
mna04650  Natural killer cell mediated cytotoxicity
mna04660  T cell receptor signaling pathway
mna04662  B cell receptor signaling pathway
mna04664  Fc epsilon RI signaling pathway
mna04666  Fc gamma R-mediated phagocytosis
mna04668  TNF signaling pathway
mna04720  Long-term potentiation
mna04722  Neurotrophin signaling pathway
mna04725  Cholinergic synapse
mna04726  Serotonergic synapse
mna04730  Long-term depression
mna04810  Regulation of actin cytoskeleton
mna04910  Insulin signaling pathway
mna04912  GnRH signaling pathway
mna04914  Progesterone-mediated oocyte maturation
mna04915  Estrogen signaling pathway
mna04916  Melanogenesis
mna04917  Prolactin signaling pathway
mna04919  Thyroid hormone signaling pathway
mna04921  Oxytocin signaling pathway
mna04926  Relaxin signaling pathway
mna04928  Parathyroid hormone synthesis, secretion and action
mna04929  GnRH secretion
mna04934  Cushing syndrome
mna04935  Growth hormone synthesis, secretion and action
mna05010  Alzheimer disease
mna05022  Pathways of neurodegeneration - multiple diseases
mna05034  Alcoholism
mna05132  Salmonella infection
mna05135  Yersinia infection
mna05160  Hepatitis C
mna05161  Hepatitis B
mna05163  Human cytomegalovirus infection
mna05164  Influenza A
mna05165  Human papillomavirus infection
mna05166  Human T-cell leukemia virus 1 infection
mna05167  Kaposi sarcoma-associated herpesvirus infection
mna05170  Human immunodeficiency virus 1 infection
mna05200  Pathways in cancer
mna05205  Proteoglycans in cancer
mna05206  MicroRNAs in cancer
mna05210  Colorectal cancer
mna05211  Renal cell carcinoma
mna05212  Pancreatic cancer
mna05213  Endometrial cancer
mna05214  Glioma
mna05215  Prostate cancer
mna05216  Thyroid cancer
mna05218  Melanoma
mna05219  Bladder cancer
mna05220  Chronic myeloid leukemia
mna05221  Acute myeloid leukemia
mna05223  Non-small cell lung cancer
mna05224  Breast cancer
mna05225  Hepatocellular carcinoma
mna05226  Gastric cancer
mna05230  Central carbon metabolism in cancer
mna05231  Choline metabolism in cancer
mna05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
KEGG Orthology (KO) [BR:mna00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    107533801 (MAP2K1)
   04012 ErbB signaling pathway
    107533801 (MAP2K1)
   04014 Ras signaling pathway
    107533801 (MAP2K1)
   04015 Rap1 signaling pathway
    107533801 (MAP2K1)
   04370 VEGF signaling pathway
    107533801 (MAP2K1)
   04371 Apelin signaling pathway
    107533801 (MAP2K1)
   04668 TNF signaling pathway
    107533801 (MAP2K1)
   04066 HIF-1 signaling pathway
    107533801 (MAP2K1)
   04068 FoxO signaling pathway
    107533801 (MAP2K1)
   04072 Phospholipase D signaling pathway
    107533801 (MAP2K1)
   04071 Sphingolipid signaling pathway
    107533801 (MAP2K1)
   04024 cAMP signaling pathway
    107533801 (MAP2K1)
   04022 cGMP-PKG signaling pathway
    107533801 (MAP2K1)
   04151 PI3K-Akt signaling pathway
    107533801 (MAP2K1)
   04150 mTOR signaling pathway
    107533801 (MAP2K1)
 09140 Cellular Processes
  09141 Transport and catabolism
   04140 Autophagy - animal
    107533801 (MAP2K1)
  09143 Cell growth and death
   04114 Oocyte meiosis
    107533801 (MAP2K1)
   04210 Apoptosis
    107533801 (MAP2K1)
   04218 Cellular senescence
    107533801 (MAP2K1)
  09144 Cellular community - eukaryotes
   04510 Focal adhesion
    107533801 (MAP2K1)
   04540 Gap junction
    107533801 (MAP2K1)
   04550 Signaling pathways regulating pluripotency of stem cells
    107533801 (MAP2K1)
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    107533801 (MAP2K1)
 09150 Organismal Systems
  09151 Immune system
   04613 Neutrophil extracellular trap formation
    107533801 (MAP2K1)
   04620 Toll-like receptor signaling pathway
    107533801 (MAP2K1)
   04650 Natural killer cell mediated cytotoxicity
    107533801 (MAP2K1)
   04660 T cell receptor signaling pathway
    107533801 (MAP2K1)
   04662 B cell receptor signaling pathway
    107533801 (MAP2K1)
   04664 Fc epsilon RI signaling pathway
    107533801 (MAP2K1)
   04666 Fc gamma R-mediated phagocytosis
    107533801 (MAP2K1)
   04062 Chemokine signaling pathway
    107533801 (MAP2K1)
  09152 Endocrine system
   04910 Insulin signaling pathway
    107533801 (MAP2K1)
   04929 GnRH secretion
    107533801 (MAP2K1)
   04912 GnRH signaling pathway
    107533801 (MAP2K1)
   04915 Estrogen signaling pathway
    107533801 (MAP2K1)
   04914 Progesterone-mediated oocyte maturation
    107533801 (MAP2K1)
   04917 Prolactin signaling pathway
    107533801 (MAP2K1)
   04921 Oxytocin signaling pathway
    107533801 (MAP2K1)
   04926 Relaxin signaling pathway
    107533801 (MAP2K1)
   04935 Growth hormone synthesis, secretion and action
    107533801 (MAP2K1)
   04919 Thyroid hormone signaling pathway
    107533801 (MAP2K1)
   04928 Parathyroid hormone synthesis, secretion and action
    107533801 (MAP2K1)
   04916 Melanogenesis
    107533801 (MAP2K1)
  09153 Circulatory system
   04270 Vascular smooth muscle contraction
    107533801 (MAP2K1)
  09156 Nervous system
   04725 Cholinergic synapse
    107533801 (MAP2K1)
   04726 Serotonergic synapse
    107533801 (MAP2K1)
   04720 Long-term potentiation
    107533801 (MAP2K1)
   04730 Long-term depression
    107533801 (MAP2K1)
   04722 Neurotrophin signaling pathway
    107533801 (MAP2K1)
  09158 Development and regeneration
   04380 Osteoclast differentiation
    107533801 (MAP2K1)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    107533801 (MAP2K1)
   05206 MicroRNAs in cancer
    107533801 (MAP2K1)
   05205 Proteoglycans in cancer
    107533801 (MAP2K1)
   05230 Central carbon metabolism in cancer
    107533801 (MAP2K1)
   05231 Choline metabolism in cancer
    107533801 (MAP2K1)
   05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
    107533801 (MAP2K1)
  09162 Cancer: specific types
   05210 Colorectal cancer
    107533801 (MAP2K1)
   05212 Pancreatic cancer
    107533801 (MAP2K1)
   05225 Hepatocellular carcinoma
    107533801 (MAP2K1)
   05226 Gastric cancer
    107533801 (MAP2K1)
   05214 Glioma
    107533801 (MAP2K1)
   05216 Thyroid cancer
    107533801 (MAP2K1)
   05221 Acute myeloid leukemia
    107533801 (MAP2K1)
   05220 Chronic myeloid leukemia
    107533801 (MAP2K1)
   05218 Melanoma
    107533801 (MAP2K1)
   05211 Renal cell carcinoma
    107533801 (MAP2K1)
   05219 Bladder cancer
    107533801 (MAP2K1)
   05215 Prostate cancer
    107533801 (MAP2K1)
   05213 Endometrial cancer
    107533801 (MAP2K1)
   05224 Breast cancer
    107533801 (MAP2K1)
   05223 Non-small cell lung cancer
    107533801 (MAP2K1)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    107533801 (MAP2K1)
   05022 Pathways of neurodegeneration - multiple diseases
    107533801 (MAP2K1)
  09165 Substance dependence
   05034 Alcoholism
    107533801 (MAP2K1)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    107533801 (MAP2K1)
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    107533801 (MAP2K1)
   05135 Yersinia infection
    107533801 (MAP2K1)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    107533801 (MAP2K1)
   05170 Human immunodeficiency virus 1 infection
    107533801 (MAP2K1)
   05161 Hepatitis B
    107533801 (MAP2K1)
   05160 Hepatitis C
    107533801 (MAP2K1)
   05164 Influenza A
    107533801 (MAP2K1)
   05163 Human cytomegalovirus infection
    107533801 (MAP2K1)
   05167 Kaposi sarcoma-associated herpesvirus infection
    107533801 (MAP2K1)
   05165 Human papillomavirus infection
    107533801 (MAP2K1)
  09176 Drug resistance: antineoplastic
   01521 EGFR tyrosine kinase inhibitor resistance
    107533801 (MAP2K1)
   01522 Endocrine resistance
    107533801 (MAP2K1)
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01001 Protein kinases [BR:mna01001]
    107533801 (MAP2K1)
Enzymes [BR:mna01000]
 2. Transferases
  2.7  Transferring phosphorus-containing groups
   2.7.12  Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
    2.7.12.2  mitogen-activated protein kinase kinase
     107533801 (MAP2K1)
Protein kinases [BR:mna01001]
 Serine/threonine kinases: STE group
  STE7 family
   107533801 (MAP2K1)
SSDB
Motif
Pfam: Pkinase PK_Tyr_Ser-Thr Pkinase_fungal Kinase-like Seadorna_VP7 NAD_binding_6
Other DBs
NCBI-GeneID: 107533801
NCBI-ProteinID: XP_016064131
LinkDB
Position
Unknown
AA seq 393 aa
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKV
GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE
CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL
REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY
SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY
GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF
IKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV
NT seq 1182 nt   +upstreamnt  +downstreamnt
atgcccaagaagaagccgacgcccatccagctgaacccggccccagacggctccgcggtt
aacgggaccagctcggcggagaccaacctggaggctttgcagaagaaactggaagaactg
gagctggatgagcaacagcggaagcgccttgaggcctttcttacccagaagcagaaggtg
ggggaactgaaggatgatgactttgagaagatcagtgagctgggtgctggaaatggtggt
gtggtgttcaaggtctcccacaagccgtccggcctggttatggccagaaagctaattcac
ctggagatcaaacctgcgatccggaaccagatcataagggagctgcaggttctacatgag
tgtaactccccatacatcgtgggcttctatggtgcattctacagcgatggcgagatcagc
atctgcatggaacacatggatgggggttccttggatcaagtcctgaagaaagctggaaga
attcctgaacaaattttaggaaaagttagcattgctgtaataaaaggcctgacatatctg
agggagaagcacaagattatgcatagagatgtcaagccttccaacatcctggtgaactcc
cgtggggagatcaagctctgtgactttggggtcagcgggcagctcattgactccatggcc
aactccttcgtgggcacaaggtcctacatgtcgccagaaagactccaggggactcattac
tcggtgcagtcggacatctggagcatggggctctctctggttgagatggctgttgggagg
tatcccatccctcctccagatgcgaaggagctggagctgatgtttgggtgccaggtggag
ggagatgcggctgagacaccacccaggccaaggacccctgggaggcctcttagctcttat
ggaatggacagccgacctcccatggcaatttttgagttgttggattacatagtcaacgag
cctcctccaaaactgcccagtggagtattcagtctggaatttcaagattttgtgaataaa
tgcttaataaaaaaccctgcagagagagcagatttgaaacaactcatggttcatgctttt
atcaagagatctgatgctgaggaagtggattttgcaggttggctctgctccaccatcggc
cttaaccagcccagcacaccgacccatgcagctggtgtctaa

DBGET integrated database retrieval system